IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 10 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $373,000 | +37200.0% | 65,700 | +16325.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 400 | +300.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 100 | -99.2% | 0.00% | – |
| Q3 2015 | $80,000 | +263.6% | 12,593 | +349.8% | 0.00% | – |
| Q2 2015 | $22,000 | +1000.0% | 2,800 | +845.9% | 0.00% | – |
| Q2 2014 | $2,000 | +100.0% | 296 | +0.7% | 0.00% | – |
| Q3 2013 | $1,000 | – | 294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,205,000 | $8,351,000 | 3.49% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 622,744 | $4,316,000 | 1.61% |
| MARATHON CAPITAL MANAGEMENT | 25,000 | $173,000 | 0.09% |
| Granite Investment Partners, LLC | 125,251 | $868,000 | 0.08% |
| REGIONS FINANCIAL CORP | 30,500 | $211,000 | 0.00% |
| CIBC Private Wealth Group, LLC | 29,297 | $203,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 576 | $4,000 | 0.00% |
| Formidable Asset Management, LLC | 300 | $2,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,211 | $8,000 | 0.00% |
| CITIGROUP INC | 25 | $0 | 0.00% |